Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphine SCHEMBL27910547 | 0.96 | FDPS (0.39) | FDPSALDH1A1 | |
| SCHEMBL191751 | 0.92 | — | — | |
| Ammonia Solution, Strong SCHEMBL2471319 | 0.89 | FDPS (0.39) | FDPSALDH1A1 | |
| Water SCHEMBL26643057 | 0.89 | FDPS (0.39) | FDPSALDH1A1 | |
| SCHEMBL309833 | 0.88 | FDPS (0.43) | FDPSALDH1A1TSHRTDP1ESR1 | |
| SCHEMBL3030228 | 0.87 | FDPS (0.35) | FDPSALDH1A1TSHR | |
| SCHEMBL8029117 | 0.87 | FDPS (0.36) | FDPSALDH1A1TSHRESR1ESR2 | |
| Hydrochloric Acid SCHEMBL28606232 | 0.86 | FDPS (0.38) | FDPSALDH1A1 | |
| SCHEMBL20298311 | 0.85 | FDPS (0.44) | FDPSTSHRGGPS1 | |
| SCHEMBL12778804 | 0.85 | TSHR (0.37) | FDPSALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 953 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119002096-A | Method for manufacturing contact lens | 望隼科技股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| EP-3665144-B1 | PROCESS FOR RECOVERING 3-METHYLBUT-3-EN-1-OL | BASF SE (DE) | 2023-08-02 | — | — | EP | claimed |
| EP-3976362-B1 | METHOD FOR MAKING OPAQUE COLORED SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2023-06-07 | — | — | EP | claimed |
| CN-110997606-B | Process for recovering 3-methylbut-3-en-1-ol | 巴斯夫欧洲公司 | 2023-03-10 | — | — | CN | claimed |
| US-11584097-B2 | Method for making opaque colored silicone hydrogel contact lenses | ALCON INC. (CH) | 2023-02-21 | — | — | US | claimed |
| EP-3976362-A1 | METHOD FOR MAKING OPAQUE COLORED SILICONE HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2022-04-06 | — | — | EP | claimed |
| US-10919827-B2 | Process for recovering 3-methylbut-3-en-1-ol | BASF SE (DE) | 2021-02-16 | — | — | US | claimed |
| US-20200376787-A1 | METHOD FOR MAKING OPAQUE COLORED SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2020-12-03 | — | — | US | claimed |
| WO-2020240440-A1 | METHOD FOR MAKING OPAQUE COLORED SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2020-12-03 | — | — | WO | claimed |
| US-20200239394-A1 | PROCESS FOR RECOVERING 3-METHYLBUT-3-EN-1-OL | BASF SE (DE) | 2020-07-30 | — | — | US | claimed |
| US-20090146330-A1 | METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2009-06-11 | — | — | US | claimed |
| EP-0908744-B1 | Silicone hydrogel polymers | JOHNSON & JOHNSON VISION PROD (US) | 2002-12-18 | — | — | EP | claimed |
| US-6020445-A | Silicone hydrogel polymers | JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) | 2000-02-01 | — | — | US | claimed |
| EP-0908744-A1 | Silicone hydrogel polymers | JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) | 1999-04-14 | — | — | EP | claimed |
| EP-0324980-B1 | Norbornene formulations with longer pot lives and lower molding temperatures | GOODRICH CO B F (US) | 1995-03-29 | — | — | EP | claimed |
| EP-0324979-B1 | Norbornene formulations with longer pot lives | GOODRICH CO B F (US) | 1994-03-23 | — | — | EP | claimed |
| EP-0324980-A2 | Norbornene formulations with longer pot lives and lower molding temperatures | THE B.F. GOODRICH COMPANY (US) | 1989-07-26 | — | — | EP | claimed |
| EP-0324979-A2 | Norbornene formulations with longer pot lives | THE B.F. GOODRICH COMPANY (US) | 1989-07-26 | — | — | EP | claimed |
| US-4792540-A | POLYMERIZATION CATALYST FORMED FROM ALKALI METAL ALCOHOLATE AND LACTAM WITH HIGHER ALCOHOL | STAMICARBON B.V. (NL) | 1988-12-20 | — | — | US | claimed |
| EP-0238143-A1 | Process for preparing an alkali metal lactamate | STAMICARBON B.V. (NL) | 1987-09-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11584097-B2 | Method for making opaque colored silicone hydrogel contact lenses | COIL, CRYAB, CRYAA | FDPS 3030/4885ALDH1A1 3383/4885TSHR 3017/4885 |
| US-20200376787-A1 | METHOD FOR MAKING OPAQUE COLORED SILICONE HYDROGEL CONTACT LENSES | COIL, CRYAB, CRYAA | FDPS 3030/4885ALDH1A1 3383/4885TSHR 3017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.